nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurandrenolide—Folliculitis—Sorafenib—liver cancer	0.13	0.136	CcSEcCtD
Flurandrenolide—Secondary infection—Epirubicin—liver cancer	0.103	0.107	CcSEcCtD
Flurandrenolide—Secondary infection—Doxorubicin—liver cancer	0.0953	0.0992	CcSEcCtD
Flurandrenolide—Leukoderma—Epirubicin—liver cancer	0.0712	0.0741	CcSEcCtD
Flurandrenolide—Leukoderma—Doxorubicin—liver cancer	0.0659	0.0686	CcSEcCtD
Flurandrenolide—Eruption—Epirubicin—liver cancer	0.0492	0.0512	CcSEcCtD
Flurandrenolide—Folliculitis—Epirubicin—liver cancer	0.0481	0.0501	CcSEcCtD
Flurandrenolide—Eruption—Doxorubicin—liver cancer	0.0455	0.0474	CcSEcCtD
Flurandrenolide—Folliculitis—Doxorubicin—liver cancer	0.0445	0.0464	CcSEcCtD
Flurandrenolide—Skin discolouration—Epirubicin—liver cancer	0.0335	0.0349	CcSEcCtD
Flurandrenolide—Skin discolouration—Doxorubicin—liver cancer	0.031	0.0323	CcSEcCtD
Flurandrenolide—Dermatitis contact—Epirubicin—liver cancer	0.0299	0.0312	CcSEcCtD
Flurandrenolide—Infection—Sorafenib—liver cancer	0.029	0.0302	CcSEcCtD
Flurandrenolide—Dermatitis contact—Doxorubicin—liver cancer	0.0277	0.0288	CcSEcCtD
Flurandrenolide—Hypersensitivity—Sorafenib—liver cancer	0.0215	0.0224	CcSEcCtD
Flurandrenolide—Pruritus—Sorafenib—liver cancer	0.0207	0.0215	CcSEcCtD
Flurandrenolide—Rash—Sorafenib—liver cancer	0.0184	0.0192	CcSEcCtD
Flurandrenolide—Dermatitis—Sorafenib—liver cancer	0.0184	0.0192	CcSEcCtD
Flurandrenolide—Infection—Epirubicin—liver cancer	0.0107	0.0112	CcSEcCtD
Flurandrenolide—Infection—Doxorubicin—liver cancer	0.00992	0.0103	CcSEcCtD
Flurandrenolide—Hypersensitivity—Epirubicin—liver cancer	0.00795	0.00829	CcSEcCtD
Flurandrenolide—Pruritus—Epirubicin—liver cancer	0.00764	0.00796	CcSEcCtD
Flurandrenolide—Hypersensitivity—Doxorubicin—liver cancer	0.00736	0.00767	CcSEcCtD
Flurandrenolide—Pruritus—Doxorubicin—liver cancer	0.00707	0.00736	CcSEcCtD
Flurandrenolide—Rash—Epirubicin—liver cancer	0.00681	0.00709	CcSEcCtD
Flurandrenolide—Dermatitis—Epirubicin—liver cancer	0.0068	0.00708	CcSEcCtD
Flurandrenolide—Rash—Doxorubicin—liver cancer	0.0063	0.00656	CcSEcCtD
Flurandrenolide—Dermatitis—Doxorubicin—liver cancer	0.00629	0.00655	CcSEcCtD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—TAT—liver cancer	0.00247	0.0618	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptors—NR1I3—liver cancer	0.00179	0.0448	CbGpPWpGaD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1B—liver cancer	0.00168	0.042	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—NR1H4—liver cancer	0.00144	0.036	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—NR1I3—liver cancer	0.00141	0.0354	CbGpPWpGaD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALDOB—liver cancer	0.0013	0.0324	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptors—HNF4A—liver cancer	0.00124	0.031	CbGpPWpGaD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF4A—liver cancer	0.0011	0.0276	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—HNF4A—liver cancer	0.00098	0.0245	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—NR1I3—liver cancer	0.000967	0.0242	CbGpPWpGaD
Flurandrenolide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—liver cancer	0.000913	0.0228	CbGpPWpGaD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—liver cancer	0.000834	0.0209	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—SCD—liver cancer	0.000808	0.0202	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—ATF3—liver cancer	0.000788	0.0197	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—liver cancer	0.000701	0.0175	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—liver cancer	0.000677	0.0169	CbGpPWpGaD
Flurandrenolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—liver cancer	0.000666	0.0166	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptors—PPARA—liver cancer	0.000652	0.0163	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptors—ESR1—liver cancer	0.00059	0.0148	CbGpPWpGaD
Flurandrenolide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—liver cancer	0.00059	0.0148	CbGpPWpGaD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—liver cancer	0.00056	0.014	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptors—PPARG—liver cancer	0.000539	0.0135	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—AHR—liver cancer	0.00052	0.013	CbGpPWpGaD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—liver cancer	0.000519	0.013	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—PPARA—liver cancer	0.000515	0.0129	CbGpPWpGaD
Flurandrenolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—liver cancer	0.000496	0.0124	CbGpPWpGaD
Flurandrenolide—NR3C1—Circadian Clock—PPARA—liver cancer	0.000485	0.0121	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—ESR1—liver cancer	0.000467	0.0117	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—MAPK14—liver cancer	0.000461	0.0115	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—CSF2—liver cancer	0.000456	0.0114	CbGpPWpGaD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—TNF—liver cancer	0.000443	0.0111	CbGpPWpGaD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—liver cancer	0.000431	0.0108	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—PPARG—liver cancer	0.000426	0.0106	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—CSF2—liver cancer	0.000402	0.01	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—ESR1—liver cancer	0.000362	0.00906	CbGpPWpGaD
Flurandrenolide—NR3C1—Circadian Clock—SERPINE1—liver cancer	0.000361	0.00903	CbGpPWpGaD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—IL6—liver cancer	0.000357	0.00894	CbGpPWpGaD
Flurandrenolide—NR3C1—Endoderm Differentiation—APC—liver cancer	0.00035	0.00876	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—liver cancer	0.000325	0.00813	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—liver cancer	0.000322	0.00806	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—JUN—liver cancer	0.000293	0.00732	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—CDKN2A—liver cancer	0.000278	0.00695	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—MAPK8—liver cancer	0.000277	0.00693	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—liver cancer	0.000265	0.00662	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NR1H4—liver cancer	0.000249	0.00621	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—CDKN1B—liver cancer	0.000246	0.00616	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NR1I3—liver cancer	0.000244	0.00611	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—PPARA—liver cancer	0.000244	0.00609	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—IL2—liver cancer	0.000241	0.00602	CbGpPWpGaD
Flurandrenolide—NR3C1—Endoderm Differentiation—CTNNB1—liver cancer	0.000238	0.00595	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—CCND1—liver cancer	0.000235	0.00587	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—JUN—liver cancer	0.000234	0.00586	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—CTNNB1—liver cancer	0.000233	0.00582	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—MMP9—liver cancer	0.000228	0.0057	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—IL2—liver cancer	0.000212	0.00531	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—liver cancer	0.000209	0.00521	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—JUN—liver cancer	0.000207	0.00516	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—liver cancer	0.000202	0.00506	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—PPARG—liver cancer	0.000201	0.00504	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—liver cancer	0.0002	0.00501	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—liver cancer	0.000195	0.00489	CbGpPWpGaD
Flurandrenolide—NR3C1—Endoderm Differentiation—TGFB1—liver cancer	0.000192	0.00481	CbGpPWpGaD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	0.000189	0.00474	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—MYC—liver cancer	0.000188	0.00471	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—TGFB1—liver cancer	0.000188	0.0047	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—SERPINE1—liver cancer	0.000181	0.00454	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—HNF4A—liver cancer	0.000169	0.00423	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.000168	0.00419	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—TP53—liver cancer	0.000155	0.00387	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—EXOSC2—liver cancer	0.00015	0.00376	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—CTNNB1—liver cancer	0.000142	0.00354	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—IL6—liver cancer	0.000142	0.00354	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—CDKN1A—liver cancer	0.000138	0.00346	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—TP53—liver cancer	0.000136	0.00341	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000127	0.00318	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—IL6—liver cancer	0.000125	0.00312	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—STAT3—liver cancer	0.000124	0.00309	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—JUN—liver cancer	0.000123	0.00309	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000123	0.00306	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—NR1H4—liver cancer	0.00012	0.00299	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—NR1I3—liver cancer	0.000118	0.00294	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.000116	0.00291	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—liver cancer	0.000115	0.00288	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—TGFB1—liver cancer	0.000115	0.00286	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000108	0.0027	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—TNF—liver cancer	0.000107	0.00267	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—TNF—liver cancer	9.24e-05	0.00231	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—PPARA—liver cancer	8.9e-05	0.00222	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—IL6—liver cancer	8.63e-05	0.00216	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—HNF4A—liver cancer	8.15e-05	0.00204	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—ESR1—liver cancer	8.06e-05	0.00202	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—IL6—liver cancer	7.46e-05	0.00187	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—PPARG—liver cancer	7.35e-05	0.00184	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—PSMA4—liver cancer	7.13e-05	0.00178	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—PSMD10—liver cancer	7.13e-05	0.00178	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—SERPINE1—liver cancer	6.62e-05	0.00166	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—H2AFX—liver cancer	4.81e-05	0.0012	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—PPARA—liver cancer	4.28e-05	0.00107	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—MYC—liver cancer	4.19e-05	0.00105	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—MAPK14—liver cancer	3.96e-05	0.000989	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—ESR1—liver cancer	3.88e-05	0.00097	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—PPARG—liver cancer	3.54e-05	0.000885	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—SERPINE1—liver cancer	3.19e-05	0.000798	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—MYC—liver cancer	2.02e-05	0.000505	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—AKT1—liver cancer	1.4e-05	0.00035	CbGpPWpGaD
